Solius
Bainbridge Island, US · Delaware corporation · 1 known investors
Solius manufactures an FDA-cleared, personalized UVB light therapy device that analyzes skin tone to deliver controlled vitamin D-stimulating light exposure for systemic health benefits. The device targets consumers seeking sun-driven health benefits without excessive UV risk.
Founders & leadership
CK
Chris KipleExecutive Officer, Director
RW
Robert WiseExecutive Officer
DG
David GoodExecutive Officer
AM
Alexander MoffatExecutive Officer, Director, Promoter
EH
Elwood HowseDirector
RH
Rick HennesseyExecutive Officer, Director, Promoter
CA
Christopher AckerleyDirector
BP
Brett ParentDirector
SH
Scott HirschDirector
RW
Rick WhiteDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3.5MraisedMay 2026 · 2 investors · Other Health CareRule 506(b)
▶$3.5MraisedMay 2026 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chris KipleExecutive Officer, Director
- Robert WiseExecutive Officer
- Brett ParentDirector
- Scott HirschDirector
- David GoodExecutive Officer
- Christopher AckerleyDirector
- Rick WhiteDirector
- Offering amount
- $17.9M
- Amount sold
- $3.5M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$23.5MraisedMay 2026 · 11 investors · Other Health CareRule 506(b)
▶$23.5MraisedMay 2026 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Rick WhiteDirector
- Brett ParentDirector
- Scott HirschDirector
- Robert WiseExecutive Officer
- David GoodExecutive Officer
- Chris KipleExecutive Officer, Director
- Christopher AckerleyDirector
- Offering amount
- $23.5M
- Amount sold
- $23.5M
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$788.2KraisedOct 2018 · 4 investors · Other TechnologyRule 506(b)
▶$788.2KraisedOct 2018 · 4 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Brett R ParentDirector
- Elwood Denison HowseDirector
- Rick J. HenneseyExecutive Officer, Director
- William Alexander MoffatDirector
- Bob WiseExecutive Officer
- Christopher H AckerleyDirector
- Offering amount
- $12.8M
- Amount sold
- $788.2K
- Sales commissions
- $5K
- Placement agents
- Capital Suisse LLC
- First sale
- Oct 2018
- Incorporated
- Corporation, Washington
- Federal exemptions
- 06b
▶$3.1MraisedDec 2015 · 23 investors · Other TechnologyRule 506(b)
▶$3.1MraisedDec 2015 · 23 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Alexander MoffatExecutive Officer, Director, Promoter
- Elwood HowseDirector
- Rick HennesseyExecutive Officer, Director, Promoter
- Offering amount
- $7M
- Amount sold
- $3.1M
- Minimum investment
- $10K
- First sale
- Nov 2014
- Incorporated
- Corporation, Washington, 2011
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Selling Sunshine From Seattle: Solius Raises $23M to Launch New At-Home Light-Therapy Device | Life Science Washingtonlifesciencewa.org · 2026
- Solius Labs Raises $23M for FDA-Cleared Personalized UVB Therapy Device - Global Wellness Summitglobalwellnesssummit.com · 2026
- Solius Labs Secures $23.0 | Signalbasetrysignalbase.com · 2026
- Solius Labs Raises $23M for FDA-Cleared Personalized UVB Therapy Device | Fitt Insiderinsider.fitt.co · 2026
- Selling sunshine from Seattle: Solius raises $23M to launch new at-home light-therapy device – GeekWiregeekwire.com · 2026
